Cognitive Function and Fatigue After Brain Abscess
Launched by UNIVERSITY OF OSLO · Jun 23, 2021
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how patients who have been treated for a brain abscess experience cognitive problems, like difficulties with thinking and memory, and feelings of fatigue. A brain abscess is an infection in the brain that can cause serious issues, even after treatment. Researchers want to understand if these ongoing problems are due to inflammation or damage in the brain caused by the abscess. To do this, they will use special imaging and brain activity tests, which will help identify any changes in the brain that could explain these symptoms.
To participate in the trial, you need to be over 16 years old and have completed treatment for a brain abscess. Unfortunately, individuals who are unconscious, too mentally ill to participate, or have dementia cannot take part. Additionally, if you have claustrophobia that prevents you from undergoing certain tests, or if you experience panic attacks that would make it difficult to complete the procedures, you would also be excluded. If eligible, participants can expect to undergo some tests that will help researchers learn more about the brain's condition and how it relates to ongoing cognitive problems and fatigue.
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • • Patients who have completed treatment for brain abscess and who agree to participate.
- Exclusion criteria:
- • Patients who cannot undergo neuropsychological investigation due to unconsciousness
- • Patients who cannot undergo neuropsychological investigation, being mentally too ill
- • Patients who suffer from dementia
- • Patients who cannot undergo FDG-PET due to claustrophobia
- • Patients who cannot undergo EEG due to panic attacks
- • Age under 16.
About University Of Oslo
The University of Oslo, a leading research institution in Norway, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration and ethical research practices, the university harnesses its extensive expertise in various fields, including medicine, health sciences, and biomedical research. The University of Oslo actively engages in clinical trials aimed at exploring new therapies and interventions, fostering a culture of scientific inquiry, and contributing to the global understanding of health and disease. Through its commitment to excellence and rigorous methodologies, the university seeks to translate research findings into tangible benefits for patients and society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oslo, , Norway
Patients applied
Trial Officials
Bjørnar Hassel, MD, PhD
Principal Investigator
University of Oslo
Daniel Dahlberg, MD, PhD
Principal Investigator
Oslo University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials